21 July - 3 August 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Possible cause of MS?
Researchers have developed a detailed hypothesis that MS is triggered by an initial infection with a common parasite (known in the UK as threadworm), followed by infection with the Epstein Barr virus (a common virus which causes glandular fever in some people), causing certain changes in the immune system of people with a particular genetic make-up. If the theory proves to be correct, a vaccine against Epstein Bar virus could prevent MS occurring.
MS Trust link: Causes of MS
Cannabis review decision
Following a two-part review of cannabis-derived medicinal products, the Home Secretary has announced that specialist doctors will be able to legally prescribe cannabis-derived medicinal products for ‘patients with an exceptional clinical need’ by autumn this year. Further work will now be done by the MHRA (Medicines and Healthcare Products Regulatory Agency) and the Department of Health to determine what products this will actually include.
MS Trust link: Cannabis
MS Trust launches 'Move it For MS' exercise campaign for MS Awareness Week
25 April 2019
This MS Awareness Week, we are calling on people with MS to pop on their pumps and introduce a little activity into their daily routine. Staying active doesn’t need to mean running marathons or going to the gym, it’s about doing it at your own level, at your own pace. Doing it YOUR way.
Don’t judge a book by its cover – Becky’s books help the MS Trust
24 April 2019
Our supporter Becky is raising money for the MS Trust with the sale of her beautiful handmade notebooks.
EMA recommends temporary restriction on use of Lemtrada
12 April 2019
The European Medicines Agency has recommended a temporary restriction on people who should start treatment with Lemtrada while a review of side effects is carried out.